Clinical trial
Early Phase II Trials for Cocaine Medication Development - 1
NCT00000317 · New York State Psychiatric Institute, Other · Completed
Key facts
| NCT number | NCT00000317 |
|---|---|
| Title | Early Phase II Trials for Cocaine Medication Development - 1 |
| Official title | Early Phase II Trials for Cocaine Medication Development |
| Lead sponsor | New York State Psychiatric Institute, Other |
| Collaborators | National Institute on Drug Abuse (NIDA) NIH Research Foundation for Mental Hygiene, Inc. |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cocaine-Related Disorders, Substance-Related Disorders |
| Intervention type | Behavioral, Drug |
| Interventions | Risperidone, Placebo, Relapse prevention counseling |
| Enrollment | 31 |
| Start date | Aug 1, 1996 |
| Primary completion | Jul 1, 1999 |
| Completion | Jul 1, 1999 |
| First posted | Sep 21, 1999 |
| Last update posted | Jun 26, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: